Blackcurrant seed oil for prevention of atopic allergy

Blackcurrant seed oil for prevention of atopic allergy: a double-blind placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14869647

Enrollment

294

Registered

2009-11-19

Start date

2004-05-12

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis Skin and Connective Tissue Diseases Atopic dermatitis

Interventions

Blackcurrant seed oil was given to pregnant mothers and newborn infants for the first 24 months of life. Control group received olive oil as placebo. The mothers were given capsules, 3 g per day and b

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Mothers during 8th to the 16th weeks of pregnancy 2. Aged between 19 - 43 years of age

Exclusion criteria

Exclusion criteria: 1. Premature delivery 2. Need for neonatal intensive care

Design outcomes

Primary

Measure	Time frame
Prevalence of atopic dermatitis by the age of 12 months	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026